Jeanine Theresa Griffin
Radiology in Salt Lake City, UT
License number
Utah 365538-5402
Issued Date
Sep 29, 1998
Expiration Date
May 31, 2003
Category
Radiology
Type
Radiology Practical Technician
Address
Address
Salt Lake City, UT
Personal information
See more information about Jeanine Theresa Griffin at radaris.comName
Address
Phone
1880 E Sycamore Ln, Salt Lake Cty, UT 84117
1880 Sycamore Ln, Salt Lake City, UT 84117
1880 #17672, Holladay, UT 84117
1050 W 400 N St, Orem, UT 84057
15 E 1400 S Pl, Logan, UT 84321
Professional information
Control Of Infectious Microorganisms By Modulation Of Chorionic Gonadotropin-Related Protein Activity
US Patent:
6139839, Oct 31, 2000
Filed:
Sep 22, 1998
Appl. No.:
9/158565
Inventors:
William D. Odell - Salt Lake City UT
Jeanine T. Griffin - Holladay UT
Sanjeev Grover - Salt Lake City UT
Omar Caticha - Salt Lake City UT
Douglas T. Carrell - West Valley City UT
Marion L. Woods - Salt Lake City UT
Jeanine T. Griffin - Holladay UT
Sanjeev Grover - Salt Lake City UT
Omar Caticha - Salt Lake City UT
Douglas T. Carrell - West Valley City UT
Marion L. Woods - Salt Lake City UT
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 39395, A61K 3900, C07K 1600
US Classification:
4241301
Abstract:
A method of controlling, in a warm-blooded animal, an infectious microorganism expressing a chorionic gonadotropin-like growth-regulating protein comprises modulating the activity of the protein by administering to the warm-blooded animal an effective amount of an antibody capable of inhibiting the activity of the protein, the chorionic gonadotropin-like growth-regulating protein itself such that the animal develops a neutralizing immune response, or peptides that block the receptors of the chorionic gonadotropin-like growth-regulating protein in the infectious microorganism. Candida albicans is one such microorganism that can be controlled by delivering an antibody against the growth-regulating protein, CaCGLP. Mycobacteria can also be controlled by this method. A method of inhibiting transition of Candida albicans blastospores in vitro by contacting the blastospores with an antibody against CaCGLP is also disclosed.
Control Of Infectious Microorganisms By Modulation Of Chorionic Gonadotropin-Related Protein Activity
US Patent:
5811249, Sep 22, 1998
Filed:
Oct 21, 1994
Appl. No.:
8/327362
Inventors:
William D. Odell - Salt Lake City UT
Jeanine T. Griffin - Holladay UT
Omar Caticha - Salt Lake City UT
Jeanine T. Griffin - Holladay UT
Omar Caticha - Salt Lake City UT
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
G01N 3353, C07K 1614
US Classification:
435 731
Abstract:
A method of controlling, in a warm-blooded animal, an infectious microorganism expressing a chorionic gonadotropin-like growth-regulating protein comprises modulating the activity of the protein by administering to the warm-blooded animal an effective amount of an antibody capable of inhibiting the activity of the protein, the chorionic gonadotropin-like growth-regulating protein itself such that the animal develops a neutralizing immune response, or peptides that block the receptors of the chorionic gonadotropin-like growth-regulating protein in the infectious microorganism. Candida albicans is one such microorganism that can be controlled by delivering an antibody against the growth-regulating protein, CaCGLP. Mycobacteria can also be controlled by this method. A method of inhibiting transition of Candida albicans blastospores in vitro by contacting the blastospores with an antibody against CaCGLP is also disclosed.